UniSuper Management Pty Ltd Buys 23,581 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

UniSuper Management Pty Ltd increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 184,745 shares of the pharmacy operator’s stock after acquiring an additional 23,581 shares during the period. UniSuper Management Pty Ltd’s holdings in Walgreens Boots Alliance were worth $1,724,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of WBA. Brooklyn Investment Group raised its stake in shares of Walgreens Boots Alliance by 21.1% during the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after purchasing an additional 830 shares in the last quarter. First Financial Corp IN grew its holdings in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the period. CWA Asset Management Group LLC increased its position in Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 1,084 shares during the last quarter. Metis Global Partners LLC raised its stake in Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock valued at $222,000 after buying an additional 1,118 shares during the period. Finally, Harbour Investments Inc. lifted its position in shares of Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator’s stock valued at $265,000 after buying an additional 1,165 shares during the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $11.19 on Monday. The business has a fifty day moving average price of $10.83 and a two-hundred day moving average price of $9.92. The stock has a market capitalization of $9.67 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $21.74.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on WBA. StockNews.com started coverage on Walgreens Boots Alliance in a research note on Wednesday, March 26th. They issued a “hold” rating on the stock. Evercore ISI increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Bank of America lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Finally, Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.